Furthermore, Sun et al.104found that inhibition of STAT signaling, either through genetic approaches or treatment with diindolylmethane, reduced the invasiveness of bladder cancer cells, highlighting the potential of targeting STAT pathways in therapeutic strategies. The gene discussed is SOAT1; the disease is urinary bladder cancer.